CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 4,823,544	$ 2,386,314
Short-term investment securities	29,399,146	38,816,441
Interest receivable	329,711	294,240
Accounts receivable	558,530	318,744
Income tax receivable	250,308	506,866
Prepaid research and development	0	253,446
Prepaid expenses and other current assets	277,999	172,001
Total current assets	35,639,238	42,748,052
Non-current assets:
Long-term investment securities	1,511,636	0
Long-term income tax receivable	250,308	500,616
Other assets	51,314	52,139
Total assets	37,452,496	43,300,807
Current liabilities:
Accounts payable	943,378	309,060
Accrued expenses	566,003	399,576
Deferred research and development obligations	78,644	141,002
Total current liabilities	1,588,025	849,638
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock	0	0
Common stock	39,613	38,967
Additional paid-in capital	96,105,851	94,385,230
Treasury stock	(18,929,915)	(18,929,915)
Accumulated deficit	(41,351,078)	(33,043,113)
Total stockholders’ equity	35,864,471	42,451,169
Total liabilities and stockholders’ equity	$ 37,452,496	$ 43,300,807

Prepaid Research and Development in Process, Current

No definition available.

Name:	dyai_PrepaidResearchandDevelopmentinProcessCurrent
Namespace Prefix:	dyai_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).